India Mouth Ulcer Therapeutics Market Report 2023 to 2030

India Mouth Ulcer Therapeutics Market Analysis

$ 3999

The India Mouth Ulcer Therapeutics Market was valued at $27.6 Mn in 2023 and is projected to grow at a CAGR of 6.9% from 2023 to 2023, to $44.1 Mn by 2030. The key drivers of this industry are rising awareness about oral hygiene, increasing demand for rapid healing products, growing geriatric population, rise in tobacco consumption, increasing incidence of oral diseases, chemical-based toothpaste and unhealthy lifestyles etc. The industry is primarily dominated by players such as Cipla, Mylan, Dr Reddy’s, Hetero among others.

ID: IN10INPH578 CATEGORY: Pharmaceuticals GEOGRAPHY: India AUTHOR: Mahima Reddy

Buy Now

India Mouth Ulcer Therapeutics Market Executive Summary

The India Mouth Ulcer Therapeutics Market is at around $27.6 Mn in 2023 and is projected to reach $44.1 Mn in 2030, exhibiting a CAGR of 6.9% during the forecast period 2023-2030.

Canker sores, or mouth ulcers, come in three main types: minor (small and oval), major (larger and deeper), and herpetiform (multiple small ulcers that may merge). While the exact cause is unclear, risk factors include stress, hormonal changes, nutrient deficiencies, certain diseases, and oral trauma. These ulcers typically heal on their own within 1-2 weeks but can lead to complications like infections, severe pain affecting eating, and potential scarring. Prevention focuses on stress reduction, avoiding trigger foods, using gentle oral care products, and addressing potential vitamin deficiencies.

Treatment aims to relieve symptoms through topical medications, pain relief, and supportive care. Home remedies include maintaining good oral hygiene, salt water rinses, and a balanced diet. Medical attention is advised for persistent, unusual, or severe ulcers, especially if accompanied by fever or difficulty in oral functions.

A study on the prevalence of benign oral ulcerations in the Indian population found an overall prevalence of 44.5%. Most of the patients presented with recurrent aphthous ulceration (47.4%). Females (57.9%) were more commonly affected than males (42.1%). The market therefore is driven by significant factors like rising awareness about oral hygiene, growing pharmaceutical industry, and changing lifestyle factors, however, factors such as limited accessibility, and preference for traditional remedies limit market growth.

The industry is primarily dominated by players such as Cipla, Mylan, Dr Reddy’s, Hetero, Zydus, Pfizer among others.

India Mouth Ulcer Treatment Market Report 2023 to 2030

Market Dynamics

Market Growth Drivers

Increasing Awareness and Affordability: As awareness about oral health and the importance of treating mouth ulcers increases, and with rising disposable incomes, more Indians are seeking professional treatment options, driving demand for pharmaceutical products.

Growth of the Pharmaceutical Industry: India's thriving pharmaceutical industry, known for its cost-effective production capabilities, has made various mouth ulcer treatments more accessible and affordable for the domestic market.

Urbanization and Lifestyle Changes: Urbanization and changing lifestyles, often associated with increased stress levels and dietary changes, have contributed to a higher incidence of mouth ulcers, driving the need for effective treatments.

Market Restraints

Preference for Traditional Remedies: In many parts of India, there is a deep-rooted preference for traditional and home remedies for treating mouth ulcers, which can hinder the adoption of pharmaceutical products.

Limited Access in Rural Areas: Access to healthcare facilities and pharmacies in rural areas of India can be limited, restricting the availability of mouth ulcer treatments in these regions.

Regulatory Landscape and Reimbursement Scenario

The Central Drugs Standard Control Organization (CDSCO) under the Ministry of Health and Family Welfare (MoHFW) is the key pharmaceutical regulatory body in India.

The CDSCO is responsible for approving drugs, conducting clinical trials, laying down standards for drugs, controlling the quality of imported drugs, and coordinating with State Drug Control Organisations to enforce the Drugs and Cosmetics Act and Rules.

India does not have a specific regulatory framework for drug reimbursement. The main sources of healthcare financing are out-of-pocket expenditure, government schemes like the Central Government Health Scheme (CGHS) and Employees' State Insurance (ESI) Scheme, private insurance, and non-governmental organizations (NGOs). However, there is no overarching reimbursement policy or mechanism for drugs, including biologics and biosimilars, in India. The Drugs Prices Control Order 2013 governs pricing of scheduled drugs, including some biologics, by the National Pharmaceutical Pricing Authority (NPPA).

Competitive Landscape

Key Players

Here are some of the major key players in the India Mouth Ulcers Therapeutics Market:

Pfizer
Dr Reddy
Cipla
Mylan
Hetero
Teva Pharmaceuticals
Bristol-Myers Squibb Company
GlaxoSmithKline plc.
Sun Pharma
Zydus

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

India Mouth Ulcer Treatment Market Segmentation

By Treatment Drug Class

Corticosteroid
Antihistamine
Antimicrobial
Analgesic
Anesthetic
Anti-inflammatory Agents

By Treatment Formulation Type

Gel
Mouthwash
Ointment
Spray
Lozenges

Mouth Ulcer Treatment Indications

Aphthous Stomatitis
Oral Lichen Planus
Others

By End Users

Pharmacy
Online Stores
Hospitals and Clinics
Home care

Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

Analyzing historical proprietary data collected from multiple projects.
Regularly updating our existing data sets with new findings and trends.
Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

Searching through academic conferences, published research, citations, and social media platforms
Collecting and compiling diverse data to build a comprehensive and detailed database
Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
Continuously refreshing our database to ensure that the information remains current and reliable.
Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

Merging historical data from secondary research with real-time data from primary research.
Conducting thorough data validation and cleansing to remove inconsistencies and errors.
Organizing data into a structured format that is easily accessible and usable for various applications.
Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.